Por favor, inténtelo con una nueva búsqueda
Símbolo | Mercado | Moneda | ||
---|---|---|---|---|
HUGE | CSE | CAD | Demorada | |
HUGE | NASDAQ | USD | Tiempo real | |
HUGE | CBOE de Canadá | CAD | Tiempo real | |
0K9 | Fráncfort | EUR | Demorada |
FSD Pharma Inc. es una empresa biotecnológica que opera en el sector de la investigación y el desarrollo farmacéuticos. Su principal candidato es FSD-201, una palmitoiletanolamida ultramicronizada para el tratamiento de enfermedades inflamatorias. La empresa también participa en la investigación y el desarrollo de Lucid-Psych, un compuesto molecular identificado para el tratamiento de trastornos de salud mental; y Lucid-MS, un compuesto molecular identificado para el tratamiento de trastornos neurodegenerativos. FSD Pharma Inc. se constituyó en 1998 y tiene su sede en Toronto (Canadá).
Nombre | Edad | Desde | Título |
---|---|---|---|
Zeeshan Saeed | 54 | 2021 | Founder, CEO, President & Executive Co-Chairman |
Anthony John Durkacz | 48 | 2018 | Founder & Executive Co-Chairman |
Lakshmi P. Kotra | 53 | 2021 | CEO of Lucid & Director |
Ravinder Kumar | - | 2022 | Member of Advisory Board |
Albert H.C. Wong | - | 2021 | Member of Research & Clinical Advisory Board |
John McGraw | - | 2022 | Member of Advisory Board |
Peter K. Stys | - | 2021 | Member of Research & Clinical Advisory Board |
Joga Gobburu | - | 2021 | Member of Regulatory Advisory Board |
Mary Melnyk | - | 2021 | Member of Regulatory Advisory Board |
Kwok Chow | - | 2022 | Member of the Regulatory Advisory Board |
Eleanor N. Fish | - | 2021 | Member of Research & Clinical Advisory Board |
Daniele Piomelli | - | 2022 | Member of Research & Clinical Advisory Board |
Adnan Bashir | 54 | 2021 | Independent Director |
David G. P. Allan | 82 | 2022 | Member of Advisory Board |
Shannon Dunn | - | 2021 | Member of Research & Clinical Advisory Board |
Hance Clarke | - | 2021 | Member of Research & Clinical Advisory Board |
Jason D. Sawyer | - | 2022 | Member of Advisory Board |
Navdeep Jaikaria | 61 | - | Member of Advisory Board |
Kevin Harrington | 67 | 2023 | Member of Advisory Board |
Michael Zapolin | 57 | 2023 | Independent Director |
Gerald V. David | 72 | 2023 | Member of Advisory Board |
Eric William Hoskins | 62 | 2023 | Independent Director |
Alexander Bar | - | 2023 | Member of Advisory Board |
Sanjiv Chopra | 74 | 2024 | Independent Director |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores